Manulife (Manufacturers Life Insurance)’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $215K | Sell |
12,819
-1,307
| -9% | -$23.4K | ﹤0.01% | 2437 |
|
|
2025
Q4 | $226K | Sell |
14,126
-2,444
| -15% | -$36.4K | ﹤0.01% | 2469 |
|
|
2025
Q3 | $205K | Sell |
16,570
-1,362
| -8% | -$16K | ﹤0.01% | 2568 |
|
|
2025
Q2 | $207K | Buy |
17,932
+1,040
| +6% | +$12.3K | ﹤0.01% | 2547 |
|
|
2025
Q1 | $253K | Sell |
16,892
-3,934
| -19% | -$65.9K | ﹤0.01% | 2396 |
|
|
2024
Q4 | $360K | Sell |
20,826
-685
| -3% | -$13.2K | ﹤0.01% | 2379 |
|
|
2024
Q3 | $399K | Buy |
21,511
+3,457
| +19% | +$69.4K | ﹤0.01% | 2361 |
|
|
2024
Q2 | $366K | Buy |
18,054
+579
| +3% | +$10.2K | ﹤0.01% | 2332 |
|
|
2024
Q1 | $298K | Sell |
17,475
-4,311
| -20% | -$67.8K | ﹤0.01% | 2401 |
|
|
2023
Q4 | $385K | Buy |
21,786
+53
| +0.2% | +$1.07K | ﹤0.01% | 2287 |
|
|
2023
Q3 | $522K | Buy |
21,733
+4,073
| +23% | +$100K | ﹤0.01% | 2116 |
|
|
2023
Q2 | $411K | Buy |
+17,660
| New | +$399K | ﹤0.01% | 2165 |
|
|
2020
Q2 | – | Sell |
-62,504
| Closed | -$646K | – | 2857 |
|
|
2020
Q1 | $646K | Buy |
62,504
+1,343
| +2% | +$37.6K | ﹤0.01% | 1713 |
|
|
2019
Q4 | $2.06M | Sell |
61,161
-3,531
| -5% | -$159K | ﹤0.01% | 1386 |
|
|
2019
Q3 | $2.97M | Sell |
64,692
-6,327
| -9% | -$294K | ﹤0.01% | 1297 |
|
|
2019
Q2 | $3.71M | Sell |
71,019
-134
| -0.2% | -$7.86K | ﹤0.01% | 1263 |
|
|
2019
Q1 | $4.91M | Buy |
71,153
+33,776
| +90% | +$2.26M | 0.01% | 1206 |
|
|
2018
Q4 | $2.23M | Buy |
37,377
+32,998
| +754% | +$2.85M | ﹤0.01% | 1361 |
|
|
2018
Q3 | $507K | Buy |
4,379
+3,595
| +459% | +$406K | ﹤0.01% | 2282 |
|
|
2018
Q2 | $99K | Sell |
784
-69,544
| -99% | -$8.46M | ﹤0.01% | 3421 |
|
|
2018
Q1 | $7.61M | Sell |
70,328
-2,174
| -3% | -$241K | 0.01% | 1043 |
|
|
2017
Q4 | $7.94M | Buy |
72,502
+7,995
| +12% | +$798K | 0.01% | 996 |
|
|
2017
Q3 | $6.37M | Buy |
64,507
+63,379
| +5,619% | +$6.14M | 0.01% | 1051 |
|
|
2017
Q2 | $114K | Buy |
1,128
+439
| +64% | +$47.3K | ﹤0.01% | 3320 |
|
|
2017
Q1 | $80K | Sell |
689
-225
| -25% | -$26.1K | ﹤0.01% | 3255 |
|
|
2016
Q4 | $110K | Buy |
914
+76
| +9% | +$8.41K | ﹤0.01% | 3182 |
|
|
2016
Q3 | $94K | Buy |
838
+517
| +161% | +$59.6K | ﹤0.01% | 3225 |
|
|
2016
Q2 | $40K | Buy |
321
+45
| +16% | +$5.43K | ﹤0.01% | 3396 |
|
|
2016
Q1 | $32K | Buy |
276
+32
| +13% | +$3.33K | ﹤0.01% | 3398 |
|
|
2015
Q4 | $27 | Hold |
244
| – | – | ﹤0.01% | 3374 |
|
|
2015
Q3 | $24 | Sell |
244
-16
| -6% | -$1.74K | ﹤0.01% | 3422 |
|
|
2015
Q2 | $30 | Sell |
260
-7,024
| -96% | -$852K | ﹤0.01% | 3413 |
|
|
2015
Q1 | $761 | Buy |
7,284
+7,024
| +2,702% | +$748K | ﹤0.01% | 1833 |
|
|
2014
Q4 | $31 | Sell |
260
-100
| -28% | -$13.1K | ﹤0.01% | 3311 |
|
|
2014
Q3 | $53 | Hold |
360
| – | – | ﹤0.01% | 3272 |
|
|
2014
Q2 | $60K | Hold |
360
| – | – | ﹤0.01% | 3227 |
|
|
2014
Q1 | $71 | Sell |
360
-100
| -22% | -$18.9K | ﹤0.01% | 3154 |
|
|
2013
Q4 | $88 | Hold |
460
| – | – | ﹤0.01% | 3109 |
|
|
2013
Q3 | $78 | Buy |
+460
| New | +$71.4K | ﹤0.01% | 3083 |
|
Other funds holding CLB
AI
DGI
CAMG
VCM
VPM
Manulife (Manufacturers Life Insurance)'s CLB Position: Q1 2026 in Review
Manulife (Manufacturers Life Insurance) reduced its Core Laboratories (CLB) stake by 9.3% in Q1 2026, selling an estimated $23.4K and leaving 12,819 shares worth $215K. The position accounts for ﹤0.01% of the portfolio, ranked #2437.
Manulife (Manufacturers Life Insurance) first reported a position in CLB in Q3 2013 and has held it in 39 quarters since. The position peaked at $7.94M in Q4 2017. 190 funds tracked by Wall St. Rank hold CLB as of Q1 2026.
- Manulife (Manufacturers Life Insurance) held 12,819 shares of Core Laboratories worth $215K as of Q1 2026.
- Manulife (Manufacturers Life Insurance) sold 1,307 Core Laboratories shares in Q1 2026, an estimated $23.4K.
- Core Laboratories made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2437 holding.
- Manulife (Manufacturers Life Insurance) first reported a position in Core Laboratories in Q3 2013 and has held it in 39 quarters since.
- Manulife (Manufacturers Life Insurance)'s Core Laboratories position peaked at $7.94M in Q4 2017.
- 190 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2026.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.